Provided by Tiger Fintech (Singapore) Pte. Ltd.

Range Cancer Therapeutics ETF

9.77
-0.3856-3.80%
Post-market: 9.930.1561+1.60%16:05 EDT
Volume:907.00
Turnover:9.02K
Market Cap:7.63M
PE:25.72
High:9.96
Open:9.96
Low:9.77
Close:10.16
Loading ...

Company Profile

Company Name:
Range Cancer Therapeutics ETF
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
- -
Office Location:
10900 Hefner Pointe Drive,Suite 400,Oklahoma City,Oklahoma,United States
Zip Code:
73120
Fax:
405-896-5825
Introduction:
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts (“ADRs”) with a market capitalization of more than $250 million. The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. Under normal circumstances, at least 80% of the fund’s total assets will be invested in the component securities of the index.